Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
ID: 344440Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $275K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/344440

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-047.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Engineering Next-Generation Human Nervous System Microphysiological Systems" under the R21 grant mechanism. This initiative aims to support research applications focused on developing advanced human cell-derived microphysiological systems (MPS) that accurately replicate the complex architecture and physiology of the nervous system, with an emphasis on enhancing understanding of nervous system development, function, and aging in both healthy and disease states. The funding, with a maximum budget of $275,000 over two years, is open to a wide range of eligible applicants, including educational institutions, community organizations, and international entities. Interested parties should note that the application deadline is January 7, 2026, and can find further details and contact information at grantsinfo@nih.gov or through the provided link to the full announcement.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-047-Full-Announcement.html
    PAR-23-047.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is issuing a funding opportunity titled "Engineering Next-Generation Human Nervous System Microphysiological Systems" (PAR-23-047). This initiative, under the R21 grant mechanism, encourages research focused on developing advanced human cell-derived microphysiological systems (MPS) that accurately replicate the complex architecture and physiology of the nervous system. The funding aims to support innovative and high-risk projects that can enhance understanding of nervous system development, function, and aging, particularly in relation to various diseases. Key dates include application deadlines starting from January 16, 2023, with a total project budget not exceeding $275,000 for two years. Eligible applicants range from educational institutions to for-profits and international entities. The document emphasizes collaboration among diverse scientific fields, highlighting specific interests of contributing NIH institutes including mental health, aging, eye development, and substance abuse. The opportunity aims not only to advance technological capabilities in nervous system research but also to foster robust and reproducible experimental designs that could significantly impact biomedical research. The funding supports early-stage development or exploratory research with a strong emphasis on technology advancement rather than purely studying disease mechanisms.
    Similar Opportunities
    Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)," aimed at advancing research in human cell-derived microphysiological systems (MPS) that replicate complex nervous system architectures and functions. This initiative seeks innovative applications that address technological barriers in studying nervous system development and diseases, with a focus on improving physiological relevance and circuit-level activity in existing assays. The funding is open to a wide range of eligible applicants, including higher education institutions and non-profits, with a project period of up to five years and no cost-sharing requirement. Interested parties should note that the application deadline is January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-046.html.
    Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed)" aimed at supporting innovative research in the identification and development of novel compounds for the prevention and treatment of nervous system disorders. This initiative encourages applications focused on early-stage research, particularly in the areas of small molecules, biotechnology products, and biologics, with an emphasis on projects that utilize machine learning and propose preclinical evaluations of candidate drugs. The funding amount available is up to $275,000, with a submission deadline of January 7, 2025. Interested applicants can find more information and submission guidelines at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)" aimed at fostering exploratory and developmental research on brain and nervous system disorders, particularly in low- and middle-income countries (LMICs). This initiative encourages collaborative research projects that span the life cycle and address the increasing burden of neurological conditions, with a focus on building sustainable research capacity and developing culturally appropriate diagnostic and treatment strategies. Eligible applicants include a diverse range of organizations, such as historically black colleges and universities, tribal governments, and foreign entities, with no cost-sharing requirement. The application deadline is December 9, 2024, and interested parties can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries. More details can be found in the full announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-22-098.html.
    Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) to support innovative and exploratory research projects in neuroscience. This grant aims to facilitate early-stage studies that assess novel avenues of investigation, particularly those that may involve significant risk but hold the potential for breakthroughs in understanding neuroscience or developing new methodologies. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and tribal governments, with funding available up to $200,000 over two years. Interested parties should submit their applications by January 7, 2025, and can find additional information and application guidelines at the NIH website or contact grantsinfo@nih.gov for assistance.
    Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)," aimed at supporting research projects that investigate the connections between brain circuit maturation and behavioral development in rodents and non-human primates. The initiative seeks to enhance understanding of how brain region interactions evolve during pre- and postnatal development, particularly in relation to cognitive, affective, and social behaviors, while employing innovative methodologies and in vivo neural measures in awake animals. With a funding ceiling of $275,000 over a two-year period, the application deadline is set for January 7, 2025. Interested applicants can find more information and guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the "Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)" grant, aimed at fostering innovative research collaborations between U.S. institutions and scientists in low- and middle-income countries (LMICs). This initiative seeks to address a range of neurological, mental, and behavioral disorders by encouraging partnerships that enhance research capacity and develop culturally sensitive interventions tailored to the unique challenges faced by these regions. The program emphasizes the importance of addressing socioeconomic factors impacting health outcomes and aims to build sustainable research frameworks to tackle neuro-health issues across the lifespan. Interested applicants must submit their proposals by December 9, 2024, and can find additional information and application guidelines at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative, titled "New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)." This initiative aims to support proof-of-concept testing and the development of innovative neurotechnologies that can enhance the understanding of brain circuit dynamics and facilitate transformative neuroscience research. The program encourages high-risk, high-impact projects that integrate diverse scientific domains and require applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their proposals. The total estimated funding available is $10 million annually, with plans to support 15-20 awards over a maximum project period of three years. Interested applicants must adhere to strict submission guidelines, and the application deadline is January 20, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional)" aimed at exploring the manipulation of neural coordination to enhance cognitive, affective, or social processing. This grant encourages innovative research projects that investigate how specific alterations in neural activity patterns can impact cognitive functions and address molecular abnormalities related to neuropsychiatric disorders. With a budget cap of $275,000 over two years, eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and tribal governments. Proposals must adhere to strict application guidelines and demonstrate potential real-world impacts on cognitive health, with applications due by January 7, 2025. For further details, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-176.html.
    Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)." This funding initiative aims to support invasive neural recording studies that address mental health-related questions, focusing on understanding the neural circuitry and dynamics underlying complex behaviors, emotions, and cognitive functions. The R21 grant mechanism encourages innovative, short-term research proposals with a budget of up to $275,000 over two years, while emphasizing the importance of diverse research teams from various clinical fields. Interested applicants should note that the application deadline is January 7, 2025, and can find further details and guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity under the BRAIN Initiative for research on the ethical implications of advancements in neurotechnology and brain science, designated as R21 Clinical Trial Optional grants. This initiative invites multi-disciplinary teams to explore critical ethical issues related to brain research, including topics such as brain imaging, data privacy, and informed consent, with the aim of fostering diverse collaborations and addressing significant ethical challenges in the field. The total funding available is $2 million annually over three years, supporting up to eight new awards, with individual project budgets capped at $275,000 for a two-year period. Interested applicants should note that the application period opens on September 11, 2024, and closes on October 9, 2026; for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov.